| Name: | NEOPHARM LABS USA INC. |
| Jurisdiction: | New York |
| Legal type: | DOMESTIC BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 24 Oct 2016 (8 years ago) |
| Entity Number: | 5027229 |
| ZIP code: | 12260 |
| County: | Albany |
| Place of Formation: | New York |
| Address: | 99 WASHINGTON AVENUE, SUITE 700, ALBANY, NY, United States, 12260 |
| Principal Address: | 865 BOUL MICHELE-BOHEC, BLAINVILLE, QC, Canada, FFJ7-C5J6 |
Shares Details
Shares issued 200
Share Par Value 0
Type NO PAR VALUE
| Name | Role | Address |
|---|---|---|
| REGISTERED AGENT SOLUTIONS, INC. | Agent | 99 WASHINGTON AVE., STE. 700, ALBANY, NY, 12260 |
| Name | Role | Address |
|---|---|---|
| REGISTERED AGENT SOLUTIONS, INC. | DOS Process Agent | 99 WASHINGTON AVENUE, SUITE 700, ALBANY, NY, United States, 12260 |
| Name | Role | Address |
|---|---|---|
| MORRIS ADLER | Chief Executive Officer | 865 BOUL MICHELE-BOHEC, BLAINVILLE, QC, Canada, FFJ7-C5J6 |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2020-11-02 | 2024-01-24 | Address | 715 ST. PAUL STREET, BALTIMORE, MD, 21202, USA (Type of address: Service of Process) |
| 2020-03-09 | 2024-01-24 | Address | 865 BOUL MICHELE-BOHEC, BLAINVILLE, CAN (Type of address: Chief Executive Officer) |
| 2016-10-24 | 2024-01-24 | Shares | Share type: NO PAR VALUE, Number of shares: 200, Par value: 0 |
| 2016-10-24 | 2020-11-02 | Address | 715 ST. PAUL STREET, BALTIMORE, MD, 21202, USA (Type of address: Service of Process) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 240124003121 | 2024-01-24 | CERTIFICATE OF CHANGE BY ENTITY | 2024-01-24 |
| 201102062692 | 2020-11-02 | BIENNIAL STATEMENT | 2020-10-01 |
| 200309060170 | 2020-03-09 | BIENNIAL STATEMENT | 2018-10-01 |
| 161024000415 | 2016-10-24 | CERTIFICATE OF INCORPORATION | 2016-10-24 |
Date of last update: 23 Nov 2024
Sources: New York Secretary of State
